Renzapride hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRenzapride hydrochloride
Drug Alias Namerenzaprida伦扎必利盐酸盐伦紮必利盐酸盐renzapriderenzapridum +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor agonistsSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptorSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlizyme
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG